DISCOUNT OPTIONSSCHEIN - ELI LILLY & CO Stock

Certificat

DE000ME903U4

Real-time Bid/Ask 05:37:45 2024-06-10 EDT
2.56 EUR / 2.6 EUR +6.61% Intraday chart for DISCOUNT OPTIONSSCHEIN - ELI LILLY & CO
Current month+23.47%
1 month+47.56%
Date Price Change
24-06-10 2.52 +4.13%
24-06-07 2.42 +11.01%
24-06-06 2.18 -0.46%
24-06-05 2.19 +0.92%
24-06-04 2.17 -2.25%

Delayed Quote Börse Stuttgart

Last update June 10, 2024 at 02:40 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer Morgan Stanley
WKN ME903U
ISINDE000ME903U4
Date issued 2024-02-20
Strike 950 $
Maturity 2024-12-20 (194 Days)
Parity 10 : 1
Emission price 1.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.52
Lowest since issue 1.2
Spread 0.04
Spread %1.55%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
850 USD
Average target price
853.8 USD
Spread / Average Target
+0.44%
Consensus